Sat, Aug 23, 2014, 8:33 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Idenix Pharmaceuticals, Inc. Message Board

  • sonquiqua sonquiqua Apr 8, 2010 8:43 PM Flag

    tyzeka royalties and HCV development

    I wonder if anyone has an idea of the royalty percentage from Tyzeka, which some estimate could sell up to $300 million worldwide. for 2009 it generated only $3 million for idix but I wonder what could be expected in the future.

    The thing I do not understand is how come the team of people that were so successful in the development and launch of Tyzeka were basically fired "to focus on HCV."

    also, I would appreciate any advice you may have on how IDIX compares to competitors in terms of technology and product offering/pipeline (VRTX, VRUS, ACHN, Etc), also considering that the medical community expects a cocktail of drugs will be the way to treat HCV.


24.500.00(0.00%)Aug 5 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.